Allison J. Ober, PhD, is a health policy and behavioral science researcher at the RAND Corporation. She has expertise in implementation science and intervention research, and has over fifteen years of experience conducting HIV prevention and substance use disorder research with underserved populations. Ober recently served as principal investigator of a study examining adaptive strategies for avoiding HIV used by young black men who have sex with men and as co-investigator of a randomized controlled trial that tested the use of a collaborative care model for implementing substance use disorder treatment in a community health center. Ober’s current research interests include increasing access to substance use disorder treatment and preventing HIV. Ober received her doctorate from the UCLA Department of Social Welfare, School of Public Affairs.

Contact: allison_ober@rand.org

FEATURED PUBLICATIONS:

1. Ober, A. J., Murray-Krezan, C., & Danovitch, I. (2025). Insights and Considerations for the START Trial and Managing Opioid Use Disorder-Reply. JAMA internal medicine, 185(9), 1177–1178.

2. Ober, A. J., Murray-Krezan, C., Page, K., Friedmann, P. D., Anderson, J., Osilla, K. C., Ryzewicz, S., Huerta, S., Mazer, M. W., Hoskinson, R. A., Garvey, R., Peltz, A., Watkins, K. E., Nuckols, T., IsHak, W. W., Mariano, L. T., & Danovitch, I. (2025). Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial. JAMA internal medicine, 185(6), 624–633.

3. Ober, A. J., Skinner, D. H., Bogart, L. M., Busakwe, L., Davids, W., Mahomed, H., Ling, D., & Zweigenthal, V. (2025). Using positive deviance to enhance HIV care retention in South Africa: development of a compassion-focused program to improve the staff and patient experience. BMC global and public health, 3(1), 8.

Last updated: 11/25/2025